Combination Treatment Improves Survival in Endometrial Cancer
A new study by Northwestern Medicine researchers has shown that a combination treatment of chemotherapy and radiation significantly improves survival rates in patients with high-risk endometrial cancer. The study, which was published in the Journal of Clinical Oncology, found that patients who received the combined treatment had a 35% lower risk of death compared to those who received chemotherapy alone. The findings of the study suggest that a combination of chemotherapy and radiation should be the standard of care for high-risk endometrial cancer patients. The study also found that patients who received the combination treatment had a lower risk of cancer recurrence. Endometrial cancer is the most common gynecologic cancer in the United States, and this new treatment option could have a significant impact on patient outcomes.